Abeona Therapeutics Provides Update on Initial Subjects in Sanfilippo Type A Gene Therapy Trial, Demonstrating Encouraging Early ...
NEW YORK, NY and CLEVELAND, OH--(Marketwired - August 02, 2016) - Abeona Therapeutics Inc. (NASDAQ: ABEO) ABO-102 (AAV-SGSH) delivers first-in-man AAV-based gene therapy delivered by single intravenous injection to treat central nervous system and …